Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA.
Elsheikh B, Severyn S, Zhao S, Kline D, Linsenmayer M, Kelly K, Tellez M, Bartlett A, Heintzman S, Reynolds J, Sterling G, Weaver T, Rajneesh K, Kolb SJ, Arnold WD.
Elsheikh B, et al. Among authors: kline d.
Front Neurol. 2021 May 20;12:650535. doi: 10.3389/fneur.2021.650535. eCollection 2021.
Front Neurol. 2021.
PMID: 34093395
Free PMC article.